A Phase 3, Randomized, Placebo-Controlled, Double-Blinded Trial to Evaluate the Safety, Tolerability, and Immunogenicity of a Multivalent Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Infants
Latest Information Update: 17 Nov 2025
At a glance
- Drugs PF 06760805 (Primary)
- Indications Staphylococcal infections
- Focus Adverse reactions; Registrational
- Acronyms BEATRIX
- Sponsors Pfizer
Most Recent Events
- 16 Sep 2025 New trial record